These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34388221)

  • 1. Public perceptions and knowledge of cholesterol management in a multi-ethnic Asian population: A population-based survey.
    Lim CY; Ho JS; Huang Z; Gao F; Tan SY; Koh WP; Chua T; Low LP; Tan HC; Yoon S
    PLoS One; 2021; 16(8):e0256218. PubMed ID: 34388221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol complacency in Australia: time to revisit the basics of cardiovascular disease prevention.
    Carrington MJ; Retegan C; Johnston CI; Jennings GL; Stewart S
    J Clin Nurs; 2009 Mar; 18(5):678-86. PubMed ID: 19077020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The A-SACT (Achievement in Singapore of Cholesterol Targets) study in patients with coronary heart disease.
    Ho KT; Chin KW; Ng KS; Alemao E; Rajagopalan S; Yin D
    Am J Cardiovasc Drugs; 2006; 6(6):383-91. PubMed ID: 17192128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge of Heart Disease, Preventive Behavior and Source of Information in a Multi-ethnic Asian Population: A Population-Based Survey.
    Huang Z; Yap QV; Chan YH; Ho JS; Tan SY; Koh WP; Chua T; Yoon S
    J Community Health; 2021 Feb; 46(1):31-40. PubMed ID: 32415522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public perceptions, knowledge and awareness of cholesterol management in Singapore: a prospective pilot study.
    Aung TH; Go YY; Low LP; Chua T
    Singapore Med J; 2013 Jan; 54(1):32-5. PubMed ID: 23338914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, determinants and association of unawareness of diabetes, hypertension and hypercholesterolemia with poor disease control in a multi-ethnic Asian population without cardiovascular disease.
    Man REK; Gan AHW; Fenwick EK; Gan ATL; Gupta P; Sabanayagam C; Tan N; Wong KH; Wong TY; Cheng CY; Lamoureux EL
    Popul Health Metr; 2019 Dec; 17(1):17. PubMed ID: 31806040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-Lowering Therapies: Risks in Women and Evidence-Based Options.
    Shah T; Virani SS
    Tex Heart Inst J; 2018 Aug; 45(4):238-239. PubMed ID: 30374235
    [No Abstract]   [Full Text] [Related]  

  • 8. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
    Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applicability and potential clinical effects of 2013 cholesterol guidelines on major cardiovascular events.
    Ko MJ; Kim YJ; Park CM; Lee SM; Lee WJ; Pencina MJ; Navar-Boggan AM; Park DW
    Am Heart J; 2015 Sep; 170(3):598-605.e7. PubMed ID: 26385045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IMPROVE-IT clinical implications. Should the "high-intensity cholesterol-lowering therapy" strategy replace the "high-intensity statin therapy"?
    Masana L; Pedro-Botet J; Civeira F
    Atherosclerosis; 2015 May; 240(1):161-2. PubMed ID: 25795557
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is statin treatment for children safe and effective?].
    Marchetti F; Cannioto Z
    Recenti Prog Med; 2008 Dec; 99(12):599-601. PubMed ID: 19388217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asian patients with dyslipidemia in an urban population: Effect of ethnicity on their LDL-cholesterol treatment goals.
    Tan NC; Koh KH; Goh CC; Koh YL; Goh SC
    J Clin Lipidol; 2016; 10(2):410-9. PubMed ID: 27055972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study.
    Ho H; Shi Y; Chua J; Tham YC; Lim SH; Aung T; Wong TY; Cheng CY
    JAMA Ophthalmol; 2017 Mar; 135(3):196-202. PubMed ID: 28097295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.
    Alla VM; Agrawal V; DeNazareth A; Mohiuddin S; Ravilla S; Rendell M
    Drugs; 2013 Jul; 73(10):1025-54. PubMed ID: 23754124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
    Capriotti T
    Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
    [No Abstract]   [Full Text] [Related]  

  • 16. A multicentre, open-label, observational local study to evaluate the low-density lipoprotein cholesterol-lowering effect of ezetimibe as prescribed in daily routine practice in the South African population.
    Raal F; Schamroth C; Patel J; Becker P
    Cardiovasc J Afr; 2007; 18(5):325-9. PubMed ID: 17985033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
    Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
    Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.
    Hebert PR; Gaziano JM; Chan KS; Hennekens CH
    JAMA; 1997 Jul 23-30; 278(4):313-21. PubMed ID: 9228438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study.
    Paragh G; Márk L; Zámolyi K; Pados G; Ofner P
    Clin Drug Investig; 2007; 27(9):647-60. PubMed ID: 17705573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.